The impact of targeted screening for latent tuberculosis in people living with HIV

The impact of targeted screening for latent tuberculosis in people living with HIV

Why is this important?

  • Targeted LTBI screening of all PLHIV residing in low TB burden countries improves diagnosis, treatment uptake and outcomes.

Principle results

  • 1,053 patients; median age: 42 years (interquartile range: 36–49).
  • Ethnicity: 47.3% (498) Black African ethnicity, 46.8% (388) White ethnicity; 51.1% born in sub-Saharan Africa, 40.0% born in Europe and Central Asia.
  • 11.2% (118) of PLHIV tested positive for DLIG.
  • 117 PLHIV were positive for ITL, 85.5% (100) started chemoprophylaxis; compliance rate: 96% (n = 96/100).
  • Positivity to DLIG, ITL, univariate analysis:
    • Black African ethnicity: odds ratio (OR) of 1.
    • South Asian ethnicity: OR 1.06; P=0.84.
    • Country of birth in sub-Saharan Africa: OR of 7.80; P<0.001.
    • Southeast Asia and Pacific: OR 5.79; P<0.001.
  • 81.4% of patients (96/118) from sub-Saharan Africa tested positive (DLIG positivity rate: 17.8%).
  • DLIG positivity rate for patients of Black African and South Asian ethnicity: 18.1% for both.
  • Yield based on threshold used for testing by DLIG: TB incidence greater than 150 cases/100,000 plus all countries in sub-Saharan Africa at birth: 89.8% of LTBI cases were correctly identified, and testing was reduced by 46.1%.


  • This is a prospective, systematic and programmatic LTBI screening intervention for PLHIV in care in Leicester, UK, to understand LTBI screening uptake/uptake. of chemoprophylaxis and related factors.
  • Funding: no funding has been communicated.


  • The overall test positivity rate by DLIG is underestimated.
  • Country-specific TB incidence was only collected at one time point.

#impact #targeted #screening #latent #tuberculosis #people #living #HIV

مقالات ذات صلة

اترك تعليقاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *

زر الذهاب إلى الأعلى